Mark J Levin's Net Worth
Estimate Recalculated Feb 10, 2025 10:59PM EST
Who is Mark J Levin
Mark J Levin has an estimated net worth of $140 Million. This is based on reported shares across multiple companies, which include RHYTHM PHARMACEUTICALS, INC., CONSTELLATION PHARMACEUTICALS INC, Fulcrum Therapeutics, Inc., Revolution Medicines, Inc., PLIANT THERAPEUTICS, INC., Editas Medicine, Inc., Jounce Therapeutics, Inc., Voyager Therapeutics, Inc., Blueprint Medicines Corp, Nurix Therapeutics, Inc., Global Blood Therapeutics, Inc., Sage Therapeutics, Inc., Relay Therapeutics, Inc., MyoKardia Inc, Neon Therapeutics, Inc., Foundation Medicine, Inc., ZAFGEN, INC., Allena Pharmaceuticals, Inc., Decibel Therapeutics, Inc., Eleven Biotherapeutics, Inc., CytomX Therapeutics, Inc., and MILLENNIUM PHARMACEUTICALS INC.
SEC CIK
Mark J Levin's CIK is 0001180428
Past Insider Trading and Trends
2005 was Mark J Levin's most active year for acquiring shares with 9 total transactions. Mark J Levin's most active month to acquire stocks was the month of May. 2007 was Mark J Levin's most active year for disposing of shares, totalling 851 transactions. Mark J Levin's most active month to dispose stocks was the month of October. 2005 saw Mark J Levin paying a total of $6,232,514.93 for 1,535,844 shares, this is the most they've acquired in one year. In 2008 Mark J Levin cashed out on 4,382,974 shares for a total of $56,918,624.00, their largest year based on trade value.
Attention insiders:Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
